
Affinity AI
Leveraging cutting-edge AI-driven protein design technologies to deliver custom, high-quality affinity reagents at unprecedented speed
Founders: Timothy P. Jenkins, Oliver Morell, Esperanza Rivera-de-Torre
We strive to use scientific research to solve problems around the world. For this reason, several companies have been started and patents filed by members or alumni from the group.

Leveraging cutting-edge AI-driven protein design technologies to deliver custom, high-quality affinity reagents at unprecedented speed
Founders: Timothy P. Jenkins, Oliver Morell, Esperanza Rivera-de-Torre

Combotope Therapeutics ApS is a biotech company (CRO) that develops antibodies against combotopes (combined glycotopes and epitopes), primarily for therapeutic purposes (e.g., therapeutic antibodies and CAR-T/M therapies).
Founders: Dr. Klas Ola Blixt, Dr. Søren Nyboe Jakobsen, Andreas H. Laustsen

Agrobiomics is a BioAg company harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
Founders: Andreas H. Laustsen, Jonas A. Jürgensen

VenomAid Diagnostics ApS is a biotech and medtech company developing diagnostic kits for snakebite envenomings based on antibody technologies.
Founders: Andreas H. Laustsen, Cecilie Knudsen, Rasmus U. W. Friis, Søren Helweg Dam, Aleksander M. Haack, Jonas A. Jürgensen

Chromologics ApS is a biotech company developing fungal fermentation processes for novel natural colors for use in both food and non-food applications.
Founders: Andreas H. Laustsen

Bactolife ApS is a biotech company developing protein-based products for prevention and treatment of gastrointestinal infections.
Founders: Andreas H. Laustsen, Sandra W. Thrane

Antag Therapeutics ApS is a biotech company developing biotherapeutics against metabolic diseases
Founders: Andreas H. Laustsen

VenomAb IVS was a biotech company aiming towards developing novel snakebite antivenoms based on human monoclonal antibodies.
Founders: Andreas H. Laustsen, Mikael Engmark

Biosyntia ApS is a biotech company developing bacterial fermentation solutions for fine and specialty chemicals and novel screening systems based on synthetic biology.
Founders: Andreas H. Laustsen
We aim for our discoveries to reach the people who need them. Patents are one step on that route.
5 further applications are on file but not yet published, so they are not listed here.